QUIA PHARMA
0.00 SEK
0.00 %
Less than 1K followers
QUIA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
0.00 %
-66.67 %
-73.68 %
-82.76 %
-88.28 %
-93.49 %
-99.98 %
-100.00 %
-100.00 %
QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Read moreMarket cap
1.97M SEK
Turnover
17.74K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Quia Pharma klargör avsikt inför avnotering
Lago Kapital säger upp marknadsgarantavtalet med Quia Pharma AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools